| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/16/2022 | LogicBio Therapeutics, Inc. | LOGC | Disposition | Common Stock | 22.3k | $0.00 | $0 | | 11/16/2022 |
| 11/16/2022 | LogicBio Therapeutics, Inc. | LOGC | Disposition | Stock Option (right to buy) | 44.5k | $0.73 | $32.5k | | 11/16/2022 |
| 11/16/2022 | LogicBio Therapeutics, Inc. | LOGC | Disposition | Stock Option (right to buy) | 12.5k | $0.38 | $4.8k | | 11/16/2022 |
| 06/17/2022 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 12.5k | $0.38 | $4.8k | | 06/17/2022 |
| 06/11/2021 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 12.5k | $4.59 | $57.4k | | 06/11/2021 |
| 05/06/2021 | Nurix Therapeutics, Inc. | NRIX | Grant | Director Stock Option (right to buy) | 17.5k | $27.38 | $479.2k | | 05/06/2021 |
| 01/01/2021 | LogicBio Therapeutics, Inc. | LOGC | Exercise | Restricted Stock Units | 3.3k | $0.00 | $0 | | 01/01/2021 |
| 06/19/2020 | LogicBio Therapeutics, Inc. | LOGC | Grant | Restricted Stock Units | 3.3k | $0.00 | $0 | | 06/19/2020 |
| 06/19/2020 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 10k | $7.96 | $79.6k | | 06/19/2020 |
| 12/19/2019 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 10.9k | $12.65 | $137.5k | | 12/19/2019 |
| 10/18/2018 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 24.1k | $10.00 | $241k | | 10/18/2018 |